Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Operating activities:    
Net loss $ (15,877) $ (13,809)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 888 866
Inventory allowance expense 157 0
Provision for doubtful accounts (109) 55
Loss on disposal of property and equipment 54 0
Gain on change in fair value of warrant liabilities (520) (3,037)
Stock-based compensation expense 1,294 1,105
Accretion of final payment fee of debt 45 48
Amortization of debt discounts 39 41
Gain on change in fair value of contingent liabilities (17) (58)
Common stock contribution to 401(k) plan 118 0
Unrealized loss (gain) on foreign currency transactions 234 (273)
Changes in operating assets and liabilities:    
Accounts receivable (678) (382)
Inventories (198) (836)
Prepaid expense and other assets 757 (122)
Accounts payable 210 328
Accrued liabilities 215 (851)
Accrued restructuring cost 0 95
Deferred revenues 584 (29)
Net cash used in operating activities (12,804) (16,859)
Investing activities:    
Acquisition of property and equipment (31) (248)
Net cash used in investing activities (31) (248)
Financing activities:    
Proceeds from issuance of common stock and warrants, net 0 10,919
Principal payments on note payable (994) (38)
Proceeds from exercise of stock options 0 42
Net cash (used in) provided by financing activities (994) 10,923
Effect of exchange rate changes on cash (94) 39
Net decrease in cash (13,923) (6,145)
Cash at beginning of period 27,813 16,846
Cash at end of period 13,890 10,701
Supplemental disclosure of cash flow activities    
Cash paid for interest 238 188
Cash paid for income taxes 0 2
Supplemental disclosure of non-cash activities    
Transfer of inventory to equipment 684 496
Share issuance for common stock contribution to 401(k) plan 508 0
Share issuance for employee bonuses 230 0
Equipois sales earn-out 28 47
Equipois supply earn-out 0 189
Cumulative retrospective adjustment to retained earnings for ASU 2016-09 adoption 0 171
April 2017 warrant issuance $ 0 $ 3,301